Clinical trials recruiting in Palmerston North, New Zealand

Phase breakdown

Conditions recruiting in Palmerston North, New Zealand

Recruiting trials in Palmerston North, New Zealand

• A Phase 1/1b Study to Evaluate Safety, Tolerability and Pharmacokinetics of ZL-1503 in Healthy Volunteers and Participants With Moderate to Severe Atopic Dermatitis
  NCT07235384 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female)
• A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)
  NCT06065748 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Phase 1a/1b Study of TRB-061 in Healthy Participants & Patients With Atopic Dermatitis
  NCT06934252 · Phase: Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female)
• Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
  NCT04613596 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
  NCT07028853 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male

Common questions

How many clinical trials are recruiting in Palmerston North, New Zealand?

5 recruiting trials have at least one study site in Palmerston North, New Zealand.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.